Patient details: fulminant hepatic failure
| Patient no | Age at diagnosis (y), sex | Non-caeruloplasmin copper (μg/l)2-154 | Caeruloplasmin2-150 (g/l) | Liver copper2-151 (μg/g) | Radiocopper study | Kayser-Fleischer rings | Urine copper2-152 (μg/24 h) | Histology |
| 23 | 11, F | 462 | 0.08 | 380 | – | Present | – | Cirrhosis |
| 24 | 12, F | – | Low2-153 | 1100 | – | Present | – | Cirrhosis |
| 25 | 15, F | 925 | 0.15 | 1847 | – | Present | 6437 | Cirrhosis |
| 26 | 15, F | – | Low2-153 | 420 | – | Absent | – | Cirrhosis |
| 27 | 16, F | 1743 | 0.21 | 767 | – | Present | 9375 | Cirrhosis |
| 28 | 18, M | 500 | 0.09 | 600 | – | Present | 844 | Cirrhosis |
| 29 | 44, F | 1330 | 0.14 | 717 | – | Absent | – | Cirrhosis |
| 30 | 54, F | 325 | 0.18 | 1526 | – | Present | 2268 | Cirrhosis/CAH |
↵2-150 Normal caeruloplasmin 0.2–0.45 g/l;
↵2-151 normal liver copper 15–60 μg/g dry weight liver;
↵2-152 normal urine copper less than 100 μg/24 h;
↵2-153 caeruloplasmin quantitated in optical density units;
↵2-154 normal non-caeruloplasmin copper less than 375 μg/l, could not be quantitated in two patients as caeruloplasmin measured in OD units.
C/W WD: radiocopper study consistent with the diagnosis of Wilson's disease; CAH, chronic active hepatitis; FHF, fulminant hepatic failure.